Kidney Transplant: Comparing rATG and Basiliximab

We are studying whether rATG is more effective than basiliximab in preventing kidney transplant rejection in sensitized patients without pre-existing antibodies. This trial aims to improve outcomes for kidney transplant recipients.

>2 yearsConfirmation phase (III)No PlaceboStandard MedicinesInjectionNephrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Simulect
Simulect is a medicine used to help prevent the body from rejecting a transplanted kidney.
Thymoglobuline
Thymoglobuline is a medicine used to prevent and treat organ transplant rejection by reducing the body's immune response.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Anti-T Lymphocyte Immunoglobulin For Human Use
Anti-T lymphocyte immunoglobulin is a preparation of antibodies that reduces activity of immune T cells to prevent or treat organ transplant rejection.
Basiliximab
Basiliximab is a substance that helps prevent organ rejection by blocking immune cell activation after transplant.
Rabbit

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Grafalon
Grafalon Sct
Thymoglobulin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire Amiens Picardie
Nephrology department
Amiens, France
University Hospital Of Clermont-Ferrand
Nephrology
Beaumont, France
CHU De Rouen
Nephrology
Bois-Guillaume, France
Sponsor: Centre Hospitalier Regional Universitaire De Tours
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.